Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-5-27
pubmed:abstractText
We have earlier shown that the treatment of A10 vascular smooth muscle cells with S-nitroso-N-acetyl-penicillamine (SNAP); nitric oxide donor (NO) for 24 h decreased the expression of natriuretic peptide receptor C (NPR-C) and adenylyl cyclase signaling. The present study was undertaken to examine the implication of different signaling mechanisms in a NO-induced response. The treatment of A10 vascular smooth muscle cells with SNAP decreased the expression of NPR-C and G(i)alpha proteins in a time-dependent manner. The expression of G(i)alpha proteins was decreased at 6 h, whereas the expression of NPR-C was attenuated at 2 h. The NPR-C-mediated inhibition of adenylyl cyclase was attenuated (approximately 50%) after 2 h of treatment and was completely abolished after 6 h of treatment. The decreased expression of NPR-C and NPR-C-mediated attenuation of adenylyl cyclase after 2 h of treatment was reversed to control levels by PD-98059, a MEK inhibitor. SNAP also modulated the ERK1/2 phosphorylation in a time-dependent manner; an increase was observed up to 2 h, and, thereafter, the ERK1/2 phosphorylation was decreased. On the other hand, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one and KT-5823 inhibitor of soluble guanylyl cyclase and protein kinase G, respectively, and Mn(III)tetrakis(4-benzoic acid)porphyrin, a scavenger of peroxynitrite, were unable to restore the SNAP-induced decreased expression of NPR-C protein and increased ERK1/2 phosphorylation to control levels. However, the decreased levels of phosphorylated ERK1/2 and G(i)alpha proteins were restored to control levels by 8-bromo-cAMP. These results indicate that a temporal relationship follows between a NO-induced decreased expression of NPR-C and G(i)alpha proteins. The decreased expression of NPR-C is mediated through cGMP-independent but MAPK-dependent pathway, whereas NO-induced decreased levels of cAMP may contribute to the decreased activation of MAPK and thereby decreased the expression of G(i)alpha proteins.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1H-(1,2,4)oxadiazolo(4,3-a)quinoxali..., http://linkedlifedata.com/resource/pubmed/chemical/8-Bromo Cyclic Adenosine..., http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase, http://linkedlifedata.com/resource/pubmed/chemical/Carbazoles, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids, http://linkedlifedata.com/resource/pubmed/chemical/Free Radical Scavengers, http://linkedlifedata.com/resource/pubmed/chemical/GTP-Binding Protein alpha..., http://linkedlifedata.com/resource/pubmed/chemical/Gnai1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/KT 5823, http://linkedlifedata.com/resource/pubmed/chemical/Metalloporphyrins, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Donors, http://linkedlifedata.com/resource/pubmed/chemical/Oxadiazoles, http://linkedlifedata.com/resource/pubmed/chemical/PD 98059, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Quinoxalines, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Atrial Natriuretic Factor, http://linkedlifedata.com/resource/pubmed/chemical/S-Nitroso-N-Acetylpenicillamine, http://linkedlifedata.com/resource/pubmed/chemical/atrial natriuretic factor receptor C, http://linkedlifedata.com/resource/pubmed/chemical/manganese(III)-tetrakis(4-benzoic...
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0363-6135
pubmed:author
pubmed:issnType
Print
pubmed:volume
296
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
H1859-67
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:19252090-8-Bromo Cyclic Adenosine Monophosphate, pubmed-meshheading:19252090-Adenylate Cyclase, pubmed-meshheading:19252090-Animals, pubmed-meshheading:19252090-Aorta, pubmed-meshheading:19252090-Carbazoles, pubmed-meshheading:19252090-Cells, Cultured, pubmed-meshheading:19252090-Down-Regulation, pubmed-meshheading:19252090-Enzyme Inhibitors, pubmed-meshheading:19252090-Flavonoids, pubmed-meshheading:19252090-Free Radical Scavengers, pubmed-meshheading:19252090-GTP-Binding Protein alpha Subunits, Gi-Go, pubmed-meshheading:19252090-MAP Kinase Signaling System, pubmed-meshheading:19252090-Metalloporphyrins, pubmed-meshheading:19252090-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:19252090-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:19252090-Mitogen-Activated Protein Kinases, pubmed-meshheading:19252090-Muscle, Smooth, Vascular, pubmed-meshheading:19252090-Nitric Oxide, pubmed-meshheading:19252090-Nitric Oxide Donors, pubmed-meshheading:19252090-Oxadiazoles, pubmed-meshheading:19252090-Phosphorylation, pubmed-meshheading:19252090-Protein Kinase Inhibitors, pubmed-meshheading:19252090-Quinoxalines, pubmed-meshheading:19252090-Rats, pubmed-meshheading:19252090-Receptors, Atrial Natriuretic Factor, pubmed-meshheading:19252090-S-Nitroso-N-Acetylpenicillamine
pubmed:year
2009
pubmed:articleTitle
Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK.
pubmed:affiliation
Department of Physiology, Groupe de recherche sur le système nerveux autonome, Faculty of Medicine, University of Montreal, Montreal, Quebec, H3C 3J7, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't